{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:04:05Z","timestamp":1780499045976,"version":"3.54.1"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/med.0000000000000062","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T11:51:25Z","timestamp":1396353085000},"page":"193-201","source":"Crossref","is-referenced-by-count":35,"title":["Interactions between adrenal-regulatory and calcium-regulatory hormones in human health"],"prefix":"10.1097","volume":"21","author":[{"given":"Jenifer M.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20211004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"R2-8-20211004","doi-asserted-by":"crossref","first-page":"10A","DOI":"10.1016\/j.amjcard.2009.10.006","article-title":"Progression of cardiovascular damage: the role of renin-angiotensin system blockade.","volume":"105","author":"Probstfield","year":"2010","journal-title":"Am J Cardiol"},{"key":"R3-8-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-8-20211004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R5-8-20211004","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-8-20211004","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenoneenalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-Left Ventricular Hypertrophy Study.","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone.","volume":"52","author":"Carbone","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1210\/jc.2012-4007","article-title":"Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study.","volume":"98","author":"Van Ballegooijen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2013.08.016","article-title":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.","volume":"63","author":"Tomaschitz","year":"2014","journal-title":"Metabolism"},{"key":"R10-8-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11906-012-0248-9","article-title":"Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease.","volume":"14","author":"Vaidya","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency.","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-8-20211004","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism.","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"R13-8-20211004","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","article-title":"Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.","volume":"321","author":"Vestergaard","year":"2000","journal-title":"BMJ"},{"key":"R14-8-20211004","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism.","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"key":"R17-8-20211004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"R18-8-20211004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00424-012-1107-x","article-title":"The influence of extracellular and intracellular calcium on the secretion of renin.","volume":"465","author":"Atchison","year":"2013","journal-title":"Pflugers Arch"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1097\/00004872-198900076-00092","article-title":"Aldosterone and pressor responses to angiotensin II in primary hyperparathyroidism.","volume":"7","author":"Fallo","year":"1989","journal-title":"J Hypertens Suppl"},{"key":"R20-8-20211004","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/1097-0142(19910215)67:4<984::AID-CNCR2820670421>3.0.CO;2-0","article-title":"Immunohistologic evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody.","volume":"67","author":"Kitazawa","year":"1991","journal-title":"Cancer"},{"key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/cs0840011","article-title":"Stimulatory action of parathyroid hormone on renin secretion in vitro: a study using isolated rat kidney, isolated rabbit glomeruli and superfused dispersed rat juxtaglomerular cells.","volume":"84","author":"Saussine","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"R22-8-20211004","first-page":"988","article-title":"Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems.","volume":"75","author":"Grant","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-8-20211004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"R24-8-20211004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1470320310391922","article-title":"25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians.","volume":"12","author":"Vaidya","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R25-8-20211004","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","article-title":"Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.","volume":"97","author":"Vaidya","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-8-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolism and parathyroid function in primary aldosteronism.","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med"},{"key":"R27-8-20211004","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","article-title":"Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.","volume":"8","author":"Rossi","year":"1995","journal-title":"Am J Hypertens"},{"key":"R28-8-20211004","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"key":"R29-8-20211004","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism.","volume":"287","author":"Chhokar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R30-8-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200507000-00001","article-title":"Bone loss in rats with aldosteronism.","volume":"330","author":"Runyan","year":"2005","journal-title":"Am J Med Sci"},{"key":"R31-8-20211004","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism.","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R32-8-20211004","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess.","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteoporos Int"},{"key":"R33-8-20211004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone.","volume":"16","author":"Beavan","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R34-8-20211004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R35-8-20211004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"R36-8-20211004","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R37-8-20211004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10157-011-0534-x","article-title":"Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients.","volume":"16","author":"Koiwa","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"R38-8-20211004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.1972.107","article-title":"Renal handling of calcium and phosphate during mineralocorticoid escape in man.","volume":"2","author":"Rastegar","year":"1972","journal-title":"Kidney Int"},{"key":"R39-8-20211004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0895-7061(97)00366-X","article-title":"Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension.","volume":"11","author":"Rossi","year":"1998","journal-title":"Am J Hypertens"},{"key":"R40-8-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6823-12-19","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.","volume":"12","author":"Tomaschitz","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"R41-8-20211004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-8-20211004","first-page":"113","article-title":"Relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism.","volume":"8","author":"Lind","year":"1994","journal-title":"J Hum Hypertens"},{"key":"R43-8-20211004","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.jhh.1001907","article-title":"Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism.","volume":"19","author":"Letizia","year":"2005","journal-title":"J Hum Hypertens"},{"key":"R44-8-20211004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/msy.2000.110240","article-title":"Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy.","volume":"128","author":"Nilsson","year":"2000","journal-title":"Surgery"},{"key":"R45-8-20211004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism.","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"R46-8-20211004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","article-title":"Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.","volume":"50","author":"Piovesan","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R47-8-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0039-6060(97)90285-3","article-title":"Time course of regression of left ventricular hypertrophy after successful parathyroidectomy.","volume":"121","author":"Stefenelli","year":"1997","journal-title":"Surgery"},{"key":"R48-8-20211004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","article-title":"Increased risk of death from primary hyperparathyroidism - an update.","volume":"28","author":"Hedback","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"R50-8-20211004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","article-title":"A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS).","volume":"75","author":"Yu","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R51-8-20211004","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/jcem-55-2-303","article-title":"A case-comparison study of hypertension and hyperparathyroidism.","volume":"55","author":"Nainby-Luxmoore","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-8-20211004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF01726908","article-title":"Reversible hypertension in primary hyperparathyroidism - pre and postoperative blood pressure in 75 cases.","volume":"62","author":"Ringe","year":"1984","journal-title":"Klin Wochenschr"},{"key":"R53-8-20211004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/hr.2010.232","article-title":"Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy.","volume":"34","author":"Rosa","year":"2011","journal-title":"Hypertens Res"},{"key":"R54-8-20211004","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism.","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R55-8-20211004","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3317\/jraas.2004.025","article-title":"Arterial stiffness and the renin-angiotensin-aldosterone system.","volume":"5","author":"Mahmud","year":"2004","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R56-8-20211004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jash.2013.09.001","article-title":"Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.","volume":"8","author":"Koumaras","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"R57-8-20211004","first-page":"286","article-title":"Hyperparathyroidism arterial hypertension and aortic stiffness: a possible bidirectional link between the adrenal cortex and the parathyroid glands that causes vascular damage Hypertens R","volume":"34","author":"Rossi","year":"2011","journal-title":"es"},{"key":"R58-8-20211004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.34.3.484","article-title":"Serum calcium and cardiovascular risk factors and diseases: the Tromso study.","volume":"34","author":"Jorde","year":"1999","journal-title":"Hypertension"},{"key":"R59-8-20211004","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","article-title":"Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study.","volume":"156","author":"Foley","year":"2008","journal-title":"Am Heart J"},{"key":"R60-8-20211004","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-4356(97)00104-2","article-title":"Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years.","volume":"50","author":"Lind","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"R61-8-20211004","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.111.172890","article-title":"Hypercalcemia reduces plasma renin via parathyroid hormone, renal interstitial calcium, and the calcium-sensing receptor.","volume":"58","author":"Atchison","year":"2011","journal-title":"Hypertension"},{"key":"R62-8-20211004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2460\/ajvr.1979.40.01.73","article-title":"Vitamin D intoxication and the pathogenesis of vitamin D nephropathy in the dog.","volume":"40","author":"Spangler","year":"1979","journal-title":"Am J Vet Res"},{"key":"R63-8-20211004","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","article-title":"Association between activating mutations of calcium-sensing receptor and Bartters syndrome.","volume":"360","author":"Watanabe","year":"2002","journal-title":"Lancet"},{"key":"R64-8-20211004","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1447-0594.2012.00945.x","article-title":"High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension.","volume":"13","author":"Mateus-Hamdan","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"R65-8-20211004","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amjcard.2012.10.021","article-title":"Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).","volume":"111","author":"Van Ballegooijen","year":"2013","journal-title":"Am J Cardiol"},{"key":"R66-8-20211004","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/jc.2012-4252","article-title":"Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.","volume":"98","author":"Van Ballegooijen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-8-20211004","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.179135","article-title":"Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study.","volume":"58","author":"Deo","year":"2011","journal-title":"Hypertension"},{"key":"R68-8-20211004","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","article-title":"Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.","volume":"31","author":"Pilz","year":"2010","journal-title":"Eur Heart J"},{"key":"R69-8-20211004","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation"},{"key":"R70-8-20211004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-51-1-144","article-title":"Primary hyperparathyroidism: possible cause of primary hyperaldosteronism in a 60-year-old woman.","volume":"51","author":"Barkan","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R71-8-20211004","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","article-title":"Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.","volume":"146","author":"Brunaud","year":"2009","journal-title":"Surgery"},{"key":"R72-8-20211004","first-page":"360","article-title":"Chronic continuous PTH infusion results in hypertension in normal subjects.","volume":"2","author":"Hulter","year":"1986","journal-title":"J Clin Hypertens"},{"key":"R73-8-20211004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"key":"R74-8-20211004","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R75-8-20211004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","article-title":"The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism.","volume":"138","author":"Kovacs","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"R76-8-20211004","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/endo-129-3-1233","article-title":"Parathyroid hormone and calcium: interactions in the control of renin secretion in the isolated, nonfiltering rat kidney.","volume":"129","author":"Helwig","year":"1991","journal-title":"Endocrinology"},{"key":"R77-8-20211004","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0026-0495(99)90075-6","article-title":"Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.","volume":"48","author":"Bernini","year":"1999","journal-title":"Metabolism"},{"key":"R78-8-20211004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.metabol.2011.09.007","article-title":"The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.","volume":"61","author":"Vaidya","year":"2012","journal-title":"Metabolism"},{"key":"R79-8-20211004","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem"},{"key":"R80-8-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcb.10343","article-title":"Vitamin D regulation of the renin-angiotensin system.","volume":"88","author":"Li","year":"2003","journal-title":"J Cell Biochem"},{"key":"R81-8-20211004","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"key":"R82-8-20211004","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","article-title":"Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.","volume":"411","author":"Tomaschitz","year":"2010","journal-title":"Clin Chim Acta"},{"key":"R83-8-20211004","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2265.2011.03991.x","article-title":"The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians.","volume":"74","author":"Vaidya","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R84-8-20211004","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI111176","article-title":"Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.","volume":"72","author":"Shoback","year":"1983","journal-title":"J Clin Invest"},{"key":"R85-8-20211004","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI111828","article-title":"Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.","volume":"75","author":"Redgrave","year":"1985","journal-title":"J Clin Invest"},{"key":"R86-8-20211004","first-page":"IV7","article-title":"Tissue renin-angiotensin systems. Their role in cardiovascular disease.","volume":"87","author":"Lee","year":"1993","journal-title":"Circulation"},{"key":"R87-8-20211004","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.peptides.2011.09.010","article-title":"A new look at the renin-angiotensin system - focusing on the vascular system.","volume":"32","author":"Nguyen Dinh Cat","year":"2011","journal-title":"Peptides"},{"key":"R88-8-20211004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6823-13-33","article-title":"Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study.","volume":"13","author":"Brown","year":"2013","journal-title":"BMC Endocr Disord"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201406000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:41:34Z","timestamp":1746168094000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201406000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0000000000000062","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}